Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund (HELX)

BATS: HELX · IEX Real-Time Price · USD
29.32
-0.33 (-1.11%)
At close: Apr 19, 2024, 2:33 PM
29.46
+0.14 (0.48%)
After-hours: Apr 19, 2024, 8:00 PM EDT
Assets $9.05M
Expense Ratio 0.50%
PE Ratio 19.23
Shares Out 300,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return -5.16%
Volume 782
Open 29.36
Previous Close 29.65
Day's Range 29.32 - 29.39
52-Week Low 25.26
52-Week High 32.92
Beta 0.96
Holdings 66
Inception Date Feb 25, 2020

About HELX

Fund Home Page

The Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund (HELX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is issued by Franklin Templeton.

Asset Class Equity
Category Health
Region Global
Stock Exchange BATS
Ticker Symbol HELX
ETF Provider Franklin Templeton

Top 10 Holdings

43.83% of assets
Name Symbol Weight
Medpace Holdings, Inc. MEDP 7.62%
Thermo Fisher Scientific Inc. TMO 4.75%
Vertex Pharmaceuticals Incorporated VRTX 4.72%
Regeneron Pharmaceuticals, Inc. REGN 4.59%
Krystal Biotech, Inc. KRYS 4.35%
Eli Lilly and Company LLY 4.34%
Danaher Corporation DHR 4.09%
Bruker Corporation BRKR 3.27%
Sartorius AG Participating Preferred SRT3.DE 3.10%
Samsung BioLogics Co Ltd 207940.KS 3.02%
View More Holdings

News

There is no news available yet.